Perspectives on the diagnosis and treatment of the relapsed/refractory multiple myeloma: highlight of the 19th European Hematology Association annual congress
10.3760/cma.j.issn.1009-9921.2014.09.004
- VernacularTitle:复发、难治多发性骨髓瘤诊治进展:第19届欧洲血液学会年会报道
- Author:
Shuhui DENG
;
Yan XU
;
Lugui QIU
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Relapsed;
Refractory;
Treatment;
European Hematology Association annual congress
- From:
Journal of Leukemia & Lymphoma
2014;23(9):520-522
- CountryChina
- Language:Chinese
-
Abstract:
Relapsed/refractory multiple myeloma (MM) is always a challenge in the field of MM treatment.In the 19th European Hematology Association (EHA) annual congress,there was a detailed and full-length description on the definition,prognosis,therapeutic strategies and new drugs of the relapsed/refractory MM.New agents with activity and good tolerability are promising in the future.
